Acumen research and consulting estimates that the global sleep apnea diagnostics market is anticipated to reach market size of around US$ 170 Mn by 2027 and is anticipated to grow at a CAGR of around 7% in terms of revenue during the forecast period 2020 – 2027. Sleep apnea is a sleep disorder which fluctuates with the breathing pattern of the patient. The patient's breathing during sleep will decrease or even stop completely. The breath (called apnea) in some cases it can be paused, lasting 10 seconds or more, and can occur 30 times or more in one hour. Daytime dreaming, heavy snoring and disturbed sleep are the symptoms of sleep apnea. About 18 million Americans are suffering from sleep apnea, while 20% are diagnosed and treated.
Market Insights
Increasing geriatric population and rise in sedentary lifestyle diseases include diabetes & other are the major factors that flourish the growth of global sleep apnea diagnostics market and is projected to grow during forecast period. The risk factor for the development and progression of sleep apnea is considered to be obesity. Additionally, technological improvements that make products more comfortable for patients and significant increase in sleep apnea disorders fuel global market growth. However, such procedures are likely to sustain high prices, limitations on the reimbursement of such products, and a low patient awareness of sleep apnea. In fact, the rise in patient preference for home healthcare services is anticipated in the near future to generate lucrative growth opportunities.
Report coverage
The market research study on “Sleep Apnea Diagnostics Market (By Product: Polysomnography Device (PSG), Clinical PSG Device, Ambulatory PSG Device, Sleep Apnea Screening Device, Actigraphy Monitoring Device, Respiratory Polygraph Oximeter, Finger Tip Oximeter, Handheld Oximeter, Wrist-worn Oximeter, Tabletop Oximeter, Others; By End-User: Hospitals & Sleep Laboratories, Home Care Settings) - Global Industry, Analysis, Market Size, Opportunities and Forecast, 2020 - 2027” offers detailed insights on the global sleep apnea diagnostics market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report also provides competitive landscape to understand the current stance of particular player. The report provides insights on global sleep apnea diagnostics market are product, end-user, and major geographic regions. The sleep apnea diagnostics market analysis is provided for major regional markets including North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each region, the market size for different segments has been covered under the scope of report.
North America accounts to hold large market share of global sleep apnea diagnostics market due to increasing awareness regarding the disease, professional sleep therapists and doctors and rise in reimbursement policies. The primary causes of obstructive medical sleep apnea are also the main drivers of the key players to launch products to the North American market. Due to the availability of qualified health care professionals and supporting government policies in the field of health services are the factors that are expected to grow the Europe market and country such as Germany, France and the UK is likely to follow the direction of North America. In the obstructive sleep-apnea treatment segment, Asia Pacific is expected to report an significant CAGR because of the high prevalence of this condition. The higher AGRs in the world are anticipated during the forecast period in Asia-Pacifical countries , such as China, Japan and India. Latin American and Middle East and Africa were less aware of the disorder and associated care services and received a lower sleep apnea-diagnostic market share.
Key Players
Major players included in this report are DeVilbiss Healthcare LLC., Cadwell Laboratories Inc., Medtronic plc, Koninklijke Philips N.V., Mindray, Natus Medical Incorporated, Resmed, Nihon Kohden Corporation, Smiths Medical, SomnoMedics, Becton, Dickinson and Company, BMC Medical Co., Ltd., Fisher & Paykel Healthcare, and others. In 2019, all the dominant players, including ResMed, Koninklijke Philips, Fisher & Paykel Healthcare, New Zealand, accounted for approximately 94.4% of the worldwide sleep apnea treatment markets and, due to their significant product advancement and growth of regional marketing approaches, the remaining players accounted for approximately 5.6% of the industry combined.
The global sleep apnea diagnostics market is segmented as below:
Market Segmentation
Sleep Apnea Diagnostics Market By Product
Polysomnography Device (PSG)
- Clinical PSG Device
- Ambulatory PSG Device
Sleep Apnea Screening Device
Actigraphy Monitoring Device
Respiratory Polygraph
Oximeter
Finger Tip Oximeter
- Handheld Oximeter
- Wrist-worn Oximeter
- Tabletop Oximeter
Others
Sleep Apnea Diagnostics Market By End-User
Hospitals & Sleep Laboratories
Home Care Settings
Sleep Apnea Diagnostics Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Sleep Apnea Diagnostics
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Sleep Apnea Diagnostics Market By Product
1.2.2.1. Global Sleep Apnea Diagnostics Market Revenue and Growth Rate Comparison By Product (2020-2027)
1.2.2.2. Global Sleep Apnea Diagnostics Market Revenue Share By Product in 2019
1.2.2.2.1. Polysomnography Device (PSG)
1.2.2.2.1. Clinical PSG Device
1.2.2.2.2. Ambulatory PSG Device
1.2.2.2.2. Sleep Apnea Screening Device
1.2.2.2.3. Actigraphy Monitoring Device
1.2.2.2.4. Respiratory Polygraph
1.2.2.2.5. Oximeter
1.2.2.2.6. Finger Tip Oximeter
1.2.2.2.6.1. Handheld Oximeter
1.2.2.2.6.2. Wrist-worn Oximeter
1.2.2.2.6.3. Tabletop Oximeter
1.2.2.2.7. Others
1.2.3. Sleep Apnea Diagnostics Market By End-User
1.2.3.1. Hospitals & Sleep Laboratories
1.2.3.2. Home Care Settings
1.2.4. Sleep Apnea Diagnostics Market By Geography
1.2.4.1. Global Sleep Apnea Diagnostics Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.4.2. North America Sleep Apnea Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.4.3. Europe Sleep Apnea Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.4.4. Asia-Pacific Sleep Apnea Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.4.5. Latin America Sleep Apnea Diagnostics Market Revenue and Growth Rate(2020-2027)
1.2.4.6. Middle East and Africa (MEA) Sleep Apnea Diagnostics Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Pure Cashmere Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Pure Cashmere Major Manufacturers in 2019
3.3. R&D Status and Technology Source of Global Pure Cashmere Major Manufacturers in 2019
3.4. Raw Materials Sources Analysis of Global Pure Cashmere Major Manufacturers in 2019
CHAPTER 4. Sleep Apnea Diagnostics MARKET By Product
4.1. Global Pure Cashmere Revenue By Product
4.2. Polysomnography Device (PSG)
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.2.3. Clinical PSG Device
4.2.4. Ambulatory PSG Device
4.3. Sleep Apnea Screening Device
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. Actigraphy Monitoring Device
4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. Respiratory Polygraph
4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.6. Oximeter
4.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.7. Finger Tip Oximeter
4.7.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.7.3. Handheld Oximeter
4.7.4. Wrist-worn Oximeter
4.7.5. Tabletop Oximeter
4.8. Others
4.8.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. Sleep Apnea Diagnostics MARKET By End-User
5.1. Global Pure Cashmere Revenue By End-User
5.2. Hospitals & Sleep Laboratories
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Home Care Settings
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. NORTH AMERICA Sleep Apnea Diagnostics MARKET BY COUNTRY
6.1. North America Sleep Apnea Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2. North America Sleep Apnea Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
6.3. U.S.
6.3.1. U.S. Sleep Apnea Diagnostics Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
6.4.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
CHAPTER 7. EUROPE Sleep Apnea Diagnostics MARKET BY COUNTRY
7.1. Europe Sleep Apnea Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. Europe Sleep Apnea Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
7.5.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
7.6.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
7.7.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
CHAPTER 8. ASIA-PACIFIC Sleep Apnea Diagnostics MARKET BY COUNTRY
8.1. Asia-Pacific Sleep Apnea Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Asia-Pacific Sleep Apnea Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
8.8.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
CHAPTER 9. LATIN AMERICA Sleep Apnea Diagnostics MARKET BY COUNTRY
9.1. Latin America Sleep Apnea Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Latin America Sleep Apnea Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
9.4. Mexico
9.4.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
CHAPTER 10. MIDDLE EAST & AFRICA Sleep Apnea Diagnostics MARKET BY COUNTRY
10.1. Middle East & Africa Sleep Apnea Diagnostics Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Middle East& Africa Sleep Apnea Diagnostics Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. GCC
10.3.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
10.4. South Africa
10.4.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
10.5. Rest of Middle East & Africa
10.5.1. Market Revenue and Forecast By Product, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By End-User, 2020 - 2027 ($Million)
CHAPTER 11. COMPANY PROFILE
11.1. DeVilbiss Healthcare LLC.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Cadwell Laboratories Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Medtronic plc
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Koninklijke Philips N.V.
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Mindray
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Natus Medical Incorporated
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies
11.7. Resmed
11.7.1. Company Snapshot
11.7.2. Overview
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. Key Developments
11.7.6. Strategies
11.8. Nihon Kohden Corporation
11.8.1. Company Snapshot
11.8.2. Overview
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. Key Developments
11.8.6. Strategies
11.9. Smiths Medical
11.9.1. Company Snapshot
11.9.2. Overview
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. Key Developments
11.9.6. Strategies
11.10. SomnoMedics
11.10.1. Company Snapshot
11.10.2. Overview
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. Key Developments
11.10.6. Strategies
11.11. Others
11.11.1. Company Snapshot
11.11.2. Overview
11.11.3. Financial Overview
11.11.4. Product Portfolio
11.11.5. Key Developments
11.11.6. Strategies
CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope
![Sleep Apnea Diagnostics Market (By Product: Polysomnography Device (PSG) [Clinical PSG Device, Ambulatory PSG Device], Sleep Apnea Screening Device, Actigraphy Monitoring Device, Respiratory Polygraph, Oximeter, Finger Tip Oximeter [Handheld Oximeter, Wrist-worn Oximeter, Tabletop Oximeter], Others; By End-User: Hospitals & Sleep Laboratories, Home Care Settings) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027](assets/images/format-png.png "Sleep Apnea Diagnostics Market (By Product: Polysomnography Device (PSG) [Clinical PSG Device, Ambulatory PSG Device], Sleep Apnea Screening Device, Actigraphy Monitoring Device, Respiratory Polygraph, Oximeter, Finger Tip Oximeter [Handheld Oximeter, Wrist-worn Oximeter, Tabletop Oximeter], Others; By End-User: Hospitals & Sleep Laboratories, Home Care Settings) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027")
